Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)-a promising drug target for the treatment of metabolic syndrome. - Masuzaki,H.; Flier,JS. (Curr Drug Targets Immune Endocr Metabol Disord, 2003)